Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction
Crossref DOI link: https://doi.org/10.1007/s11655-022-3676-7
Published Online: 2022-05-04
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Yue
Xu, Yu-ying
Jiang, Hai-jun
Wang, Lei
Zhai, Jia-wei
Zhang, Tong
Yang, Yu-fei
Text and Data Mining valid from 2022-05-04
Version of Record valid from 2022-05-04
Article History
Accepted: 25 March 2022
First Online: 4 May 2022
Free to read: This content has been made available to all.